StockData

NanoViricides, Inc. (NNVC) stock

NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.19+0.03 (+2.59%)

Close on Nov 18, 2026Market cap $30.37MP/E –Yield –

NanoViricides revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

NanoViricides's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2026 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$0–
FY2025Jun 30, 2025$0–
FY2024Jun 30, 2024$0–
FY2023Jun 30, 2023$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$0–
Q3 FY2026CQ1 2026Mar 31, 2026$0–
Q2 FY2026CQ4 2025Dec 31, 2025$0–
Q1 FY2026CQ3 2025Sep 30, 2025$0–
Q4 FY2025CQ2 2025Jun 30, 2025$0–
Q3 FY2025CQ1 2025Mar 31, 2025$0–
Q2 FY2025CQ4 2024Dec 31, 2024$0–
Q1 FY2025CQ3 2024Sep 30, 2024$0–
Q4 FY2024CQ2 2024Jun 30, 2024$0–
Q3 FY2024CQ1 2024Mar 31, 2024$0–
Q2 FY2024CQ4 2023Dec 31, 2023$0–
Q1 FY2024CQ3 2023Sep 30, 2023$0–
Q4 FY2023CQ2 2023Jun 30, 2023$0–
Q3 FY2023CQ1 2023Mar 31, 2023$0–
Q2 FY2023CQ4 2022Dec 31, 2022$0–
Q1 FY2023CQ3 2022Sep 30, 2022$0–
Q3 FY2022CQ1 2022Mar 31, 2022$0–
Q2 FY2022CQ4 2021Dec 31, 2021$0–
Q1 FY2022CQ3 2021Sep 30, 2021$0–
Q3 FY2021CQ1 2021Mar 31, 2021$0–
Q2 FY2021CQ4 2020Dec 31, 2020$0–
Q1 FY2021CQ3 2020Sep 30, 2020$0–
Q3 FY2020CQ1 2020Mar 31, 2020$0–
Q2 FY2020CQ4 2019Dec 31, 2019$0–
Q1 FY2020CQ3 2019Sep 30, 2019$0–
Q2 FY2019CQ4 2018Dec 31, 2018$0–
Q1 FY2019CQ3 2018Sep 30, 2018$0–

More NanoViricides figures

See a number that looks wrong?